InsidersTradesSigma
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the full record of transactions filed by Rowland Thomas Andrew. Director active across 1 company, notably ANI Pharmaceuticals INC. Aggregated, 7 disclosures have been published. History available since 15 November 2024. The latest transaction was disclosed on 14 February 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
7 of 7 declarations